ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test
Genetic testing is an important tool in diagnosing and managing genetic disorders. One such disorder is ADA Gene Severe combined immunodeficiency due to ADA deficiency. This rare genetic disorder is caused by a deficiency in the adenosine deaminase (ADA) enzyme, which is responsible for breaking down toxic metabolites in lymphocytes.
Test Details
The ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test is a specialized genetic test that utilizes Next-Generation Sequencing (NGS) technology. NGS genetic testing allows for the analysis of multiple genes simultaneously, providing valuable information about the specific genetic mutations or variations responsible for ADA deficiency.
Test Components and Price
The cost of the ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test is AED 4400.0. The test requires a blood sample for analysis.
Report Delivery and Method
The report for the ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test is typically delivered within 3 to 4 weeks. The test utilizes NGS technology for analysis.
Test Type and Doctor
The ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test falls under the category of Osteology Dermatology Immunology Disorders. It is typically ordered by dermatologists.
Test Department
The ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test is conducted in the Genetics department of the laboratory.
Pre Test Information
Prior to undergoing the ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test, it is recommended to provide a clinical history of the patient. Additionally, a genetic counseling session may be conducted to create a pedigree chart of family members affected by ADA Gene Severe combined immunodeficiency due to ADA deficiency.
Importance of NGS Genetic Testing
NGS genetic testing is a complex and specialized test that requires expertise in genetic analysis and interpretation. It is crucial to have the test performed by trained professionals in a certified laboratory setting. NGS genetic testing for ADA Gene Severe combined immunodeficiency due to ADA deficiency can provide vital information for diagnosis, prognosis, and treatment options. This information can help healthcare providers develop personalized treatment plans, such as enzyme replacement therapy or stem cell transplantation.
Genetic Counseling
Before and after undergoing NGS genetic testing, genetic counseling is often recommended. Genetic counseling helps individuals and their families understand the implications of the test results and make informed decisions about their healthcare.
| Test Name | ADA Gene Severe combined immunodeficiency due to ADA deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ADA Gene Severe combined immunodeficiency due to ADA deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ADA Gene Severe combined immunodeficiency due to ADA deficiency NGS Genetic DNA Test gene ADA |
| Test Details |
ADA gene severe combined immunodeficiency (SCID) is a rare genetic disorder caused by a deficiency in the adenosine deaminase (ADA) enzyme. This enzyme is responsible for breaking down toxic metabolites that accumulate in lymphocytes, which are important cells for the immune system. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the context of ADA gene SCID, NGS genetic testing can be used to identify mutations or variations in the ADA gene that are responsible for the deficiency. By identifying the specific genetic mutation causing ADA deficiency, NGS genetic testing can provide important information for diagnosis, prognosis, and treatment options. This information can help healthcare providers develop personalized treatment plans for individuals with ADA gene SCID, such as enzyme replacement therapy or stem cell transplantation. It is important to note that NGS genetic testing is a complex and specialized test that requires expertise in genetic analysis and interpretation. Therefore, it should be performed by trained professionals in a certified laboratory setting. Additionally, genetic counseling is often recommended before and after NGS testing to help individuals and their families understand the implications of the test results and make informed decisions about their healthcare. |
